While receiving standard equity grants and a stipend associated with his new non-management role beginning Jan 1., Mr. Smith, who stepped down as CEO in January 2021, was also approved by the board for the additional amount, to be paid in quarterly installments.
CHS reported a net loss Oct. 26 of $42 million for the third quarter amid continued high labor costs, fewer inpatient admissions, unfavorable payer issues and a generally challenging environment. The loss compares with net income of $111 million in the same period ending Sept. 30, 2021.
CHS did not return a call in time for publication.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
